AASLD: Platelet Booster Aids HCV Therapy (CME/CE)
SAN FRANCISCO (MedPage Today) — Patients with chronic hepatitis C virus infection and thrombocytopenia had significant improvement in virologic response when pegylated interferon alpha 2a was given with eltrombopag, results of a randomized trial showed.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com